Cel Sci CORP Form 4 insider transactions

Eyal Talor, Chief Scientific Officer of CEL SCI CORP, acquired 1,048 shares of common stock at $2.29 per share, increasing his direct beneficial ownership to 5,548 shares.

CEL SCI Corporation's Chief Financial Officer, Patricia Prichep, acquired 1,873 shares of common stock, increasing her beneficial ownership in the company.

CEL-SCI Corporation's Chief Executive Officer, Geert R. Kersten, has acquired 2,292 shares of common stock, increasing his direct beneficial ownership to 43,638 shares.

Chief Scientific Officer Talor Eyal reports acquiring 10,416 shares of CEL-SCI Corp at $0.2304 per share on March 31, 2025.

Patricia Prichep, CFO of CEL-SCI Corp, acquired 15,432 shares of common stock at a price of $0.2304 on March 31, 2025.

Geert Kersten, CEO of CEL-SCI Corp, reports the acquisition of 22,786 shares of common stock at a price of $0.2304 per share on March 31, 2025.

CEL-SCI Corp's CEO, Geert Kersten, acquired 12,940 shares of common stock at a price of $0.40 per share on December 31, 2024.

Eyal Talor, Chief Scientific Officer of CEL SCI Corp, acquired 6,001 shares of common stock at a price of $0.40 per share on December 31, 2024.

Patricia Prichep, Chief Financial & Operations Officer of CEL-SCI Corp, acquired 10,727 shares of common stock at $0.40 per share on December 31, 2024.

Eyal Talor, Chief Scientific Officer of CEL-SCI Corp, acquired 2,264 shares of common stock at $1.06 per share on September 30, 2024.

Patricia Prichep, Sr. VP of Operations at CEL-SCI Corp, acquired 4,047 shares of common stock at $1.06 per share on September 30, 2024.

Geert R. Kersten, CEO of CEL-SCI Corp, acquired 4,882 shares of common stock at $1.06 per share on September 30, 2024.

Chief Scientific Officer Eyal Talor reports the acquisition of 2,068 shares of CEL-SCI Corp common stock at $1.16 per share.

Patricia Prichep, Senior Vice President of CEL-SCI Corp, acquired 3,698 shares of common stock at a price of $1.16 per share on June 28, 2024.

CEO Geert Kersten increased his holdings in CEL-SCI Corp by purchasing 4,461 shares of common stock at $1.16 per share.

Director Robert Eugene Watson purchased 20,000 shares of CEL-SCI Corp (CVM) at $1.39 per share on May 8, 2024, increasing his direct holdings.

Patricia Prichep, Senior Vice President of CEL-SCI Corp, purchased 8,000 shares of the company's common stock at $1.39 per share on May 8, 2024.

CEL-SCI Corp's CEO, Geert Kersten, recently purchased 30,000 shares of the company's common stock at $1.39 per share.

Robert Eugene Watson, a director of CEL-SCI Corp, acquired 64,000 stock options on April 19, 2024.

Bruno Baillavoine, a director of CEL-SCI Corp, acquired 64,000 stock options on April 19, 2024.

Eyal Talor, Chief Scientific Officer of CEL-SCI Corp, reports the acquisition of 182,000 stock options.

Patricia Prichep, Senior Vice President of CEL-SCI Corp, reports the acquisition of 167,000 stock options.

CEO Geert Kersten reports acquisition of 250,000 stock options in CEL-SCI Corp.

Eyal Talor, Chief Scientific Officer of CEL-SCI Corp, reports the acquisition of 1,256 shares of common stock at a price of $1.91 per share.

Patricia Prichep, Senior Vice President of CEL-SCI Corp, acquired 2,246 shares of common stock at a price of $1.91 on March 29, 2024.

Geert R. Kersten, CEO of CEL-SCI Corp, acquired 2,709 shares of common stock at a price of $1.91 on March 29, 2024.